下一站幸福
辽宁新收行政复议案件7.2万余件 主渠道作用不断显现_我的网站
一 | 中新网沈阳8月25日电(记者 王景巍)8月25日，辽宁省政府新闻办召开贯彻实施行政复议法有关情况新闻发布会。
A US federal judge on Friday temporarily "barred the Pentagon from including Chinese biotechnology group WuXi AppTec on a list of companies believed to support Beijing's military," according to Reuters. Chinese experts said the ruling sends a positive signal for Chinese companies operating in the US, showing that Washington's arbitrary, fact-deficient national security blacklists are not beyond challenge and that firms should make greater use of legal means to defend their legitimate rights.
US District Judge James Boasberg issued an order blocking enforcement of the designation of WuXi in June after the company filed suit. WuXi in a statement welcomed the court's ruling, saying it "relieves us from the immediate adverse consequences" of the Defense Department's designation during the litigation. "We believe that the facts, as demonstrated in our court filings, will prevail after an objective and fair judicial review," a WuXi spokesperson said, according to the report.
A South China Morning Post report noted that the ruling represents an early legal victory for one of China's largest pharmaceutical research and manufacturing service providers and a setback for Washington's expanding use of national-security restrictions against major Chinese commercial companies.
Gao Lingyun, a research fellow at the Chinese Academy of Social Sciences, told the Global Times that the Pentagon's controversial "list-first, evidence-later" approach has bred massive operational uncertainty for Chinese enterprises conducting legitimate business in the US. By arbitrarily imposing restrictive labels before presenting credible proof, Washington creates an opaque and unpredictable regulatory environment that disrupts normal commercial expectations.
The US Department of Defense released its updated Section 1260H list on June 8, marking the first time WuXi AppTec was formally included, alongside Alibaba, Baidu, BYD and Unitree Robotics, among others.
On June 12, WuXi AppTec announced it had filed suit against the Department of Defense in the US District Court for the District of Columbia. The company said the department's decision was erroneous and lacked factual basis or support under applicable statutes and case law.
He Weiwen, a senior fellow at the Center for China and Globalization, noted that when Chinese companies face unfair and unjustified suppression in the US, they cannot rely solely on corporate statements or diplomatic representations; they must also protect themselves through legal means. Filing suit in federal court is entirely necessary and correct, he said.
"In the past, quite a few Chinese companies had nothing to do with so-called military matters but were hit with US countervailing and anti-dumping measures. Many won their cases after appealing to the Court of International Trade. Legal recourse is an indispensable tool and one we need to take more seriously," he said.
In January 2021, Xiaomi was placed on a similar Pentagon list. The Chinese company later announced on May 26, 2021 that a US court has removed the company's designation as a military-related company and lifted all restrictions on US persons buying or holding its stock, Reuters reported.
The designation has so far had little impact on WuXi AppTec's business. The company reported on August 3 that first-half revenue rose 38.9 percent year-on-year to 28.9 billion yuan, while net profit attributable to shareholders climbed 29.4 percent to 11.08 billion yuan — its first half-year profit above the 10-billion-yuan mark, said media reports.
When asked about US placing several Chinese technology companies including Alibaba, Tencent, BYD, on a list of firms that it says aid China's military, Chinese Foreign Ministry spokesperson Lin Jian said that China firmly opposes the US overstretching the concept of national security and formulating various types of discriminatory lists to go after Chinese businesses. "We urge the US to correct its wrongdoings, and stop the unwarranted suppression of Chinese businesses. China will do what is necessary to firmly protect their legitimate and lawful rights and interests," said Lin.
。会上，辽宁省司法厅副厅长李郊介绍，自2024年1月1日新修订的行政复议法正式实施以来，辽宁省累计新收行政复议案件7.2万余件，行政复议化解行政争议主渠道作用不断显现。其中，2025年新收3.3万余件，为2023年的2.5倍；2026年上半年新收1.5万余件，为2023年同期的2.2倍。 据悉，在主动服务发展大局方面，辽宁省着力优化营商环境，新收涉企行政复议案件3240件，累计为企业挽回经济损失约26亿元。依托基层司法所设置行政复议代办点416个，在市场主体密集区设立涉企行政复议服务点294个，开通涉企案件“绿色通道”。在民生权益保障领域，辽宁省依法审查社保、医疗、食品安全等重点民生领域案件6221件，直接纠错1951件。
二 | 在提质增效方面，辽宁省大力推行“繁简分流”办案机制，40%的案件通过简易程序审理，实现“简案快审、繁案精审”。辽宁省依法组织听证案件880件，咨询行政复议委员会专家意见近500件，实现从“书面审理”到“开门办案”的转变。 在实质性化解行政争议方面，辽宁省各级行政复议机构推行案前、案中、案后全流程调解，累计调解和解案件15032件，调撤率达26.4%。沈阳市试点推行“复调对接”模式，依托人民调解设立行政复议调解中心，邀请人民调解员参与复议调解。 在强化监督刚性方面，辽宁省通过变更、撤销、确认违法、责令履行等方式累计纠正案件8378件。针对办案中发现的普遍性问题，累计制发行政复议意见书、建议书924份，其中2025年制发的数量是新修订行政复议法实施前的近10倍，推动从个案纠错到类案规范再到系统治理。
三 | 李郊表示，在下步工作中，辽宁省各级行政复议机构将以完善行政复议制度机制为主线，以“提质增效”和“强基固本”为着力点，在“为民护企”“实质解纷”“以案促治”上下功夫，持续发挥行政复议化解行政争议主渠道作用，为辽宁振兴发展提供坚实法治保障。(完) 【编辑:何颖】。
Current article:http://elwgav.xuanliaruamibinmilangca.shop/ewfdy3e/20260826/345955.html
Published on:11:55:32